Addressing Treatment Disparities
-
Register
- Non-Member - $39
- Regular Member - $29
- Retired - $29
- Early Career Physician - $29
- Resident - $19
- Student - $19
- Associate - $19
- ASAM Staff - Free!
- International Member - $29
- Emeritus Member - $29
- Provisional Member - $29
- Fellow Member - $29
- Honorary Member - $29
- CRT Member - $29
Addressing Treatment Disparities
Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session
Overview
This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course outlines addiction related disparities and promising treatment approaches for four different populations, including rural and socioeconomically deprived, Latino, immigrant, and transgender populations.
There is an urgent need to address health disparities related to addiction among certain marginalized populations. These disparities are a result of individual, interpersonal, organizational, community and policy factors that both increase a population's risk of addiction as well as cause barriers for them to access addiction treatment. The presentations in this 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course outlines addiction related disparities and promising treatment approaches for four different populations, including rural and socioeconomically deprived, Latino, immigrant, and transgender populations. Following each presentation, presenters answer audience questions.
This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.
- Urban/Rural/Racial Disparities in Access to Buprenorphine and Opioid Treatment Programs
This presentation demonstrates disparities in access to opioid treatment programs and buprenorphine providers for the treatment of opioid use disorder and associations between access to treatment, deprivation, and rurality and treatment outcomes. Geospatial analyses were conducted at the level of block groups (600-3000 people), the smallest spatial unit for which the U.S. Census Bureau provides sociodemographic data. Compared to metropolitan block groups, access to treatment was lower in micropolitan, small town, rural, and more socioeconomically deprived areas. American Indian/Alaska Native majority block groups had lower access to treatment compared to white or other racial/ethnic majority block groups. Analysis of barriers to access is necessary to devising initiatives to enhance access to treatment for the treatment of opioid use disorders. - Screening and Intervening on Structural Determinants of Health for Minoritized Individuals in Addiction Medicine
There is an urgent need for health disparities research to reduce the disproportionate burden of negative consequences related to alcohol use among socially disadvantaged Latinos compared to other racial/ethnic groups. Cultural adaptation of evidence-based treatments, such as motivational interviewing (MI), can improve access and overall response to alcohol treatment. However, research progress has been hindered by the few theoretically-guided tests of adaptation and limited knowledge about the active ingredients and mechanisms of behavior change that might discriminate an adapted, compared to non-adapted, intervention. This presentation will examine novel mechanisms of culturally adapted MI (CAMI), including decreases in perceived acculturation stress and reduced depression and anxiety, that may improve understanding of the stress-health behavior link observed among health disparities populations and how MI can be used to disrupt this association. - ¿Cómo se dice Affordable Care? Immigrant health, access to care, and COVID-19
The health and human dignity of undocumented immigrants (and others with tenuous legal residency status) and their families are frequently challenged by immigration integration policies and enforcement activities. In the US, undocumented immigrants are systematically excluded from the health system. In this session, we will discuss immigrant status as a social determinant of health, and the impact of immigration policy on health equity and public health, with special focus on mental health, substance use, and the COVID-19 pandemic. - Health Disparities among Transgender Women
Transgender women in the US demonstrate numerous detrimental individual and structural health disparities, which impede their access to and engagement in HIV care and substance use services. These include disproportionate rates of individual-level health disparities such as lack of perceived support, cycles of incarceration, and untreated or undertreated substance use and mental health disorders, which are highly comorbid. Structural determinants of health include poverty and housing instability, lack of access to health insurance, transphobic stigma and discrimination, including transphobic stigma and discrimination specifically from healthcare providers. SUD is a demonstrated barrier to HIV care and behavioral health outcomes including poor linkage to care, ART nonadherence, increased high-cost emergency department visits, engagement in the street economy, and cycles of incarceration.
These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:
- Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
- Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
- Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine
This conference addresses all 6 ACGME Competencies.
Learning Objectives
At the end of the course, learners should be able to:
- Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
- Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
- Develop practical applications for integrating new and emerging science into practice.
- Identify gaps in the field of addiction medicine that future research can address.
- Create a network of colleagues and resources to support the learner's practice or form future research collaborations.
Registration Rates
| ASAM Learner Type | Rate |
| ASAM Member | $29 |
| Non-Member | $39 |
| Associate Member | $19 |
| Resident Member* | $19 |
| Student Member* | $19 |
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Deadline: 10/1/2025
Instructions
- Click on the Contents tab to begin this activity.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Kathleen Page, MD (Moderator)
Associate Professor
Johns Hopkins University School of Medicine
Dr. Kathleen Page, MD, is an Associate Professor in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. Her work focuses on improving access and quality of care to underserved communities. She co-founded Centro SOL to meet the health needs of Latino migrants through research, education, advocacy, and clinical care. She is the Medical Director of The Johns Hopkins Access Partnership which provides care to uninsured patients with financial need. Her research focuses on migrant health, health disparities and implementation science.
No Relevant Financial Disclosures
Solmaz Amiri, PhD
Research Assistant Professor
Washington State University
Solmaz Amiri, PhD, Research Assistant Professor, Institute for Research and Education to Advance Community Health (IREACH), Elson S. Floyd College of Medicine, Washington State University
Dr. Amiri is a Research Assistant Professor at the Elson S. Floyd College of Medicine and a core investigator with the Institute for Research and Education to Advance Community Health (IREACH) at Washington State University. She applies spatial analysis and quantitative techniques to study social, physical, and environmental factors associated with morbidity and mortality of chronic conditions. She has examined disparities in access to substance use treatment programs and the extent to which disparities in access are related to substance use treatment outcomes.
No Relevant Financial Disclosures
Christina S. Lee
PhD
| Christina Lee, PhD, is a licensed psychologist whose programmatic research utilizes and disseminates behavioral treatments for substance use to under-served and marginalized populations, with the mission of reducing health inequities related to poor mental and physical health. Dr. Lee’s expertise bridges the areas of intervention science, addiction psychology and health disparities research. Her primary research studies, funded by NIH, are: (1) developing and testing adapted evidence-based treatments (EBTs) for alcohol and substance use among racial/ethnic minority populations, (2) investigating social determinants of substance use behaviors among marginalized populations, (3) investigating mechanisms of change and psychological processes underlying addiction and its treatment, and (4) using interdisciplinary and multi-level models to implement and disseminate EBTs for substance use (alcohol, opioids). Dr. Lee received a NIH National Research Service Award (NRSA) as a PhD student, and completed a NIH funded post-doctoral fellowship at the Center for Alcohol and Addiction Studies at Brown University. Dr. Lee is on the editorial boards of the Journal of Consulting and Clinical Psychology and of Cultural Diversity: Ethnic and Minority Psychology. In 2013, Dr. Lee received the Kenerson Faculty Scholarship Award at Northeastern for her interdisciplinary research and community service, where she co-established an integrated primary care practice at the South End Community Health Center in Boston, where she currently consults to the Suboxone Support Program. In 2015, she was selected as a NIH Fellow in Randomized Behavioral Clinical Trials (NHLBI). She has been a MINT (Motivational Interviewing Network of Trainers) member since 2006 and is certified in Dialectical Behavior Therapy. |
.jpg "Speaker image")
Cathy Reback, PhD
Senior Research Scientist
Friends Research Institute
Cathy J. Reback, PhD, is a Senior Research Scientist with Friends Research Institute and the Director of the Combination Prevention Core for the UCLA Center for HIV Identification, Prevention and Treatment Services. Dr. Reback is the Founder and Executive Director of Friends Community Center the community-based site for Friends Research Institute, which provides publically funded, culturally responsive, substance use and HIV prevention services for sexual and gender minority individuals. The focus of Dr. Reback’s research is an examination of the intersection of substance use disorders and HIV risk behaviors among sexual and gender minority individuals in community settings. Dr. Reback has an extensive background in conducting community-research collaborations, managing large-scale HIV prevention and intervention programs, designing and implementing technology-based and mHealth interventions, designing and implementing venue- and street-based intervention programs, evaluating behavioral and biomedical treatment therapies for populations with substance use and mental health disorders, and conducting mixed methods research studies. Additionally, in collaboration with several community-based organizations, she has used implementation science methodology to adopt, tailor, and transfer evidenced-based interventions into public health and community settings. Dr. Reback’s community and policy work includes current and past membership on numerous local and national HIV/AIDS and substance use task forces and advisory committees.
No Relevant Financial Disclosures
CME, CE, CEU and Other Credit Types
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Maintenance of Certification (MOC) / Continuing Certification Program (CCP)
The ASAM State of the Art Course meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC
Disclosure Information
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
Key:
Complete
Next
Failed
Available
Locked